Table 1. Patient Characteristics in the Study Group.
| Value | |
| Patients, No. | 107 |
| Gender, No. (%) | |
| Women | 63 (58.9) |
| Men | 44 (41.1) |
| Age, y, mean ± SD a | 53.4 ± 9.6 |
| BMI a, kg/m 2, mean ± SD | 27.3 ± 3.9 b |
| Normal weight c, No. (%) | 35 (32.7) |
| Overweight d, No. (%) | 47 (43.9) |
| Obese e, No. (%) | 25 (23.4) |
| Baseline viral load, IU/mL | |
| < 600,000 | 34 (31.8) |
| ≥ 600,000 | 73 (68.2) |
| Liver fibrosis (Metavir) score, mean ± SD | 2.4 ± 0.6 |
| Distribution of liver fibrosis f, No. (%) | |
| F1 a | 5 (4.9) |
| F2 | 49 (48) |
| F3 | 42 (41.2) |
| F4 | 6 (5.9) |
a Abbreviations: BMI, body mass index; F, fibrosis; SD, standard deviation
b range 20.5.39.1 kg/m 2
c < 25 kg/m 2
d 25.29.9 kg/m 2
e ≥ 30 kg/m 2
f 102 patients with liver biopsy, evaluated according to the Metavir score